00:00
Growing Money
Growing Money
USD/RUB
EUR/RUB
Releases

Park Ha Biological Technology Investors Face September Deadline

September 28 marks the final day for Park Ha Biological Technology investors to seek lead plaintiff status in a pending securities class action. The lawsuit targets the company following allegations that its IPO and subsequent market performance were buoyed by artificial trading and a coordinated social media misinformation scheme.

Park Ha Biological Technology Investors Face September Deadline

The legal action, filed by The Gross Law Firm, concerns individuals who acquired Park Ha securities between December 27, 2024, and July 8, 2025. According to the complaint, the company allegedly failed to disclose that its stock price was being inflated by fraudulent promotional activity and impersonated financial professionals. Plaintiffs claim the IPO was intentionally structured with a low public float to facilitate this manipulation, rendering the company’s public disclosures regarding its operations and business prospects materially misleading.

Shareholders who purchased shares during the specified period are eligible to participate in the recovery process. Registration does not require investors to serve as lead plaintiff, and the firm notes that participation involves no upfront cost or obligation. Once registered, participants are enrolled in portfolio monitoring to receive case updates as the litigation proceeds.

Share

Comments (0)

Leave a comment

No comments yet. Be the first!